Carisma Therapeutics Inc. Accumulated Other Comprehensive Income
Carisma Therapeutics Inc. had Accumulated Other Comprehensive Income of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-04-01
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $373.00K.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $265.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $136.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 | |
| 2023-09-30 | $373.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $265.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $136.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$41.00K 10-K · filed 2024-04-01 | -$546.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | -$235.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | -$281.00K 10-Q/A · filed 2022-08-25 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |